Global Healthcare Opportunities (GHO) and CBC Group announced they have signed a definitive agreement to combine operations and create what the companies describe as the world’s largest dedicated healthcare investment manager, with more than $21 billion in assets under management.
The combined firm will unite two specialist healthcare investors with operations spanning North America, Europe, and Asia-Pacific, regions that collectively account for about 90% of global healthcare research and development spending. The new organization will employ more than 200 investment and operating professionals across 13 offices worldwide.
The firms said the merger is designed to strengthen their ability to support healthcare innovation and international growth for portfolio companies across pharmaceuticals, medical devices, diagnostics, healthcare infrastructure, healthcare IT, and life sciences. The combined platform will provide investors with access to healthcare-focused private equity, private credit, and real estate strategies.
GHO’s North American and European healthcare portfolio companies are expected to gain expanded operational support and market access across Asia-Pacific, while CBC’s Asia-based portfolio companies will benefit from broader global market expertise and international scaling capabilities.
Under the agreement, existing funds and portfolio companies at both firms will continue to be managed by their current investment teams, with no changes to governance structures, investment mandates, or ownership arrangements before closing.
The combined organization will be jointly led by Mike Mortimer and Fu Wei as Co-Chief Executives. Andrea Ponti and Alan MacKay will oversee finance and governance responsibilities at the board level. Lady Mireille Gillings, PhD, Vice Chair and Co-Founder of GHO, and Fu Wei will serve as Co-Chairs of the Board.
CBC Group currently manages approximately $10.8 billion in assets and operates from offices across Singapore, Shanghai, Beijing, Hong Kong, New York, Seoul, Abu Dhabi, Boston, San Diego, San Francisco, and Tokyo. GHO Capital manages approximately $10.5 billion in assets and is headquartered in London.
The companies said artificial intelligence applications in healthcare and life sciences will remain a strategic focus area for the combined business as healthcare innovation accelerates globally.
The transaction is expected to close in early 2027, subject to customary closing conditions and regulatory approvals. Until then, both firms will continue operating independently.
KEY QUOTES:
“The combination is about connecting leading healthcare companies and innovations with the world’s largest and most established markets and global pools of capital—by bringing together complementary strengths across Asia-Pacific, North America and Europe. Together, we are building the world’s largest dedicated healthcare investment firm to help accelerate patient access to affordable care, support innovation, and improve efficiency in addressing unmet medical needs by backing our portfolio companies and their management teams as they grow and scale impact.”
Fu Wei, Chief Executive Officer And Founder, CBC Group
“We are reinforcing our position as dedicated healthcare specialists, expanding our global reach, deepening our value creation capabilities, and empowering our portfolio companies to compete and win in an increasingly dynamic global healthcare market. By uniting our collective regional expertise, capabilities and shared commitment to identifying and growing leading healthcare companies, we are positioning ourselves to achieve strong returns, as well as further deliver on our commitment to improving global health outcomes.”
Mike Mortimer, Managing Partner And Co-Founder, GHO Capital
“This transaction represents a pivotal moment in the evolution of both firms. Our vision has always been to back high-growth, innovation-led healthcare opportunities to deliver better, faster and more accessible healthcare. In particular, AI is a fast-evolving force in healthcare and life sciences, and so AI applications in these fields will continue to be a focus moving forward. With the Asia-Pacific region accounting for 40% of global healthcare R&D spend, establishing a strong local presence is a natural and highly complementary extension of our strategy.”
Lady Mireille Gillings, PhD, Vice Chair And Co-Founder, GHO Capital
